Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003553940 | SCV004292524 | pathogenic | not provided | 2023-10-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr808*) in the ABCA4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCA4 are known to be pathogenic (PMID: 10958761, 24938718, 25312043, 26780318). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Stargardt disease (PMID: 24632595, 32845068, 33301772). It has also been observed to segregate with disease in related individuals. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005036807 | SCV005659563 | pathogenic | Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19 | 2024-02-22 | criteria provided, single submitter | clinical testing | |
Wuhan Primbio Medical Laboratory | RCV003445397 | SCV004174063 | pathogenic | Severe early-childhood-onset retinal dystrophy | 2023-11-10 | no assertion criteria provided | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr808Ter) in the ABCA4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCA4 are known to be pathogenic (PMID: 10958761, 24938718, 25312043, 26780318). This variant is not present in population databases (gnomAD no frequency). This variant has been reported in the literature in individuals affected with ABCA4-related conditions (PMID: 26780318;PMID: 35410501;PMID: 33988224). For these reasons, this variant has been classified as Pathogenic. |